BiotechTube
MicroPure Genomics

MicroPure Genomics

San Diego, United States· Est.
micropuregenomics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MicroPure Genomics is a private, pre-revenue biotech company founded in 2018 and based in San Diego, CA. It is developing the µPrep platform, a breakthrough sample preparation technology for genomics based on Electro-Hydrodynamic Purification (EHP), which promises to dramatically reduce time, complexity, and cost compared to legacy methods. The company has secured significant non-dilutive funding through SBIR grants and is incubated at EvoNexus, positioning it to advance its technology and seek commercial partnerships. Its primary challenge is transitioning from grant-funded R&D to a validated, commercial-grade product in a competitive market.

Genetics & Genomics

Technology Platform

Electro-Hydrodynamic Purification (EHP) - A beadless, pillarless, gel-free microfluidic technology for purifying and concentrating DNA and RNA for genomic analysis.

Opportunities

The global genomics market's growth creates a massive demand for faster, cheaper, and simpler sample prep, especially for long-read sequencing.
The platform's versatility and potential for automation could enable decentralized testing in clinical point-of-care and field research settings.
Successful validation could make the company an attractive strategic acquisition target for large life science tools corporations.

Risk Factors

The core technology must be successfully translated from a lab prototype to a reliable, manufacturable, and user-friendly commercial product.
The company faces intense competition from entrenched, well-funded players with dominant market share in sample preparation.
As a pre-revenue startup, it is dependent on securing additional venture funding to scale operations and commercialize, which is non-guaranteed.

Competitive Landscape

MicroPure competes in the established genomic sample preparation market dominated by giants like Qiagen, Thermo Fisher Scientific, and Illumina, who offer bead- and column-based kits. It also competes with specialized long-read prep providers like Circulomics (acquired by PacBio). Its differentiation hinges on the novel EHP physics, claiming superiority in speed, simplicity, and compatibility across fragment lengths.

More companies in Diagnostics & Precision Medicine →More companies in United States →